Capricor Therapeutics, Inc. (CAPR) Balance Sheet
As of 2026-06-30 (10-Q), Capricor Therapeutics, Inc. (CAPR) reported total assets of $368.7M, total liabilities of $122.5M and shareholders' equity of $246.2M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $20.9M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CAPRCapricor Therapeutics, Inc.Follow CAPR — free
—
Price chart with a free account
- Market cap
- 344.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 17 Nov, in 24 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.6 | 0.2 | 1.7 | 8.0 | 5.6 | 3.2 | 6.1 | 4.3 | 3.9 | 32.7 | 34.9 | 9.6 | 14.7 | 11.3 | 287.8 | 20.9 | |
| Short-term investments | — | 4.2 | 0.3 | 0.0 | 8.0 | 13.0 | 8.0 | 3.0 | 6.0 | — | 0.0 | 31.8 | 24.8 | 140.2 | 30.3 | 217.0 | |
| Current assets | 1.3 | 5.2 | 3.7 | 11.6 | 14.0 | 18.1 | 15.7 | 8.5 | 10.5 | 33.7 | 36.4 | 42.9 | 50.9 | 163.4 | 322.9 | 242.1 | |
| Total assets | 1.4 | 5.4 | 5.5 | 13.6 | 16.1 | 18.7 | 16.3 | 9.2 | 11.1 | 34.6 | 41.3 | 50.1 | 58.7 | 170.5 | 355.9 | 368.7 | |
| Current liabilities | 0.5 | 0.5 | 2.1 | 6.3 | 6.5 | 4.9 | 1.7 | 1.3 | 0.9 | 3.0 | 4.1 | 23.6 | 31.3 | 21.0 | 35.8 | 33.0 | |
| Long-term debt | — | — | — | — | — | — | — | — | 0.0 | 0.1 | 0.0 | — | — | — | — | — | |
| Total liabilities | 0.5 | 0.5 | 6.1 | 19.9 | 17.1 | 22.8 | 5.0 | 4.6 | 4.3 | 6.4 | 10.0 | 38.3 | 36.1 | 25.0 | 50.2 | 122.5 | |
| Shareholders' equity | 1.7 | 4.9 | -0.5 | -6.2 | -1.0 | -4.0 | 11.2 | 4.6 | 6.8 | 28.2 | 31.4 | 11.8 | 22.6 | 145.5 | 305.8 | 246.2 |
USD millions · SEC XBRL
Capricor Therapeutics, Inc. — questions
- How much cash does Capricor Therapeutics, Inc. have?
- $20.9M in cash and cash equivalents as of 2026-06-30.
- What are Capricor Therapeutics, Inc.'s total assets?
- $368.7M as of 2026-06-30.
- What is Capricor Therapeutics, Inc.'s shareholders' equity?
- $246.2M as of 2026-06-30.
Every figure on this page comes from Capricor Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.